Significance of Preoperative Systemic Immune Score for Stage I Gastric Cancer Patients

BACKGROUND: Determining preferences regarding the benefits of adjuvant chemotherapy (AC) for stage I GC is critical. METHODS: We retrospectively reviewed 1069 patients with pathologically confirmed stage I GC who underwent R0 gastrectomy between 2006 and 2014. Univariate and multivariate survival an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun, Cao, Long-long, Li, Ping, Xie, Jian-wei, Wang, Jia-bin, Lin, Jian-xian, Chen, Qi-yue, Lin, Mi, Tu, Ru-hong, Huang, Chang-ming, Zheng, Chao-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079442/
https://www.ncbi.nlm.nih.gov/pubmed/30116261
http://dx.doi.org/10.1155/2018/3249436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079442/
https://www.ncbi.nlm.nih.gov/pubmed/30116261
http://dx.doi.org/10.1155/2018/3249436

Ejemplares similares